Modulation of the Activity of Newly Synthesized Human Phenylalanine Hydroxylase Mutant Proteins by Low-Molecular-Weight Compounds

被引:15
|
作者
Nascimento, Catia [1 ]
Leandro, Joao [1 ]
de Almeida, Isabel Tavares [1 ]
Leandro, Paula [1 ]
机构
[1] Univ Lisbon, Metab & Genet Grp, iMed UL, Fac Farm, P-1649003 Lisbon, Portugal
来源
PROTEIN JOURNAL | 2008年 / 27卷 / 06期
关键词
Human phenylalanine hydroxylase; Phenylketonuria; Conformational disorders; Chemical chaperones; Protein stabilization;
D O I
10.1007/s10930-008-9149-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Phenylketonuria, the most frequent disorder of amino acid metabolism, is caused by a deficient activity of human phenylalanine hydroxylase (hPAH). Rescue of the enzyme activity of several recombinant hPAH mutant forms (I65T, R261Q, R270K and V388M) by low molecular weight compounds namely glycerol, trimethylamine N-oxide (TMAO) and sodium 4-phenylbutyrate (4-PB) was investigated using a prokaryotic expression model. The studied compounds were added to the culture medium, in a concentration dependent manner, simultaneously to induction of protein expression. Among the tested molecules glycerol and TMAO were able to increase the enzyme activity of the studied mutant proteins. Furthermore, a decrease in aggregates and a recovery of the active tetrameric and dimeric forms were detected. Since the addition of the studied compounds to the medium did not change the expression level of E. Coli molecular chaperones we postulate that glycerol and TMAO rescue results from a direct stabilizing effect of the newly synthesized mutant hPAH enzymes.
引用
收藏
页码:392 / 400
页数:9
相关论文
共 50 条
  • [31] LOW-MOLECULAR-WEIGHT PROTEINS (LMWP) FOR RENAL DRUG TARGETING
    FRANSSEN, EJF
    MOOLENAAR, F
    DEZEEUW, D
    HAAS, M
    VISSER, J
    MEIJER, DKF
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (06) : 2085 - 2085
  • [32] SURFACE-PROPERTIES OF SOME LOW-MOLECULAR-WEIGHT PROTEINS
    HALDER, UC
    SAHA, S
    SINHA, NK
    DAS, KP
    JOURNAL OF DISPERSION SCIENCE AND TECHNOLOGY, 1994, 15 (06) : 671 - 685
  • [33] Evidence for Targeting Low-Molecular-Weight Proteins in Hemodialysis and Hemodiafiltration
    Tsuchida, Kenji
    Nagai, Kojiro
    Yokota, Narushi
    Yamada, Satoru
    Michiwaki, Hiroyuki
    Minakuchi, Jun
    SCIENTIFIC ASPECTS OF DIALYSIS THERAPY: JSDT/ISBP ANNIVERSARY EDITION, 2017, 189 : 189 - 196
  • [34] Synthesis and anticoagulant activity of low-molecular-weight heparins
    Stolbushkina P.P.
    Bannikova G.E.
    Drozd N.N.
    Makarov V.A.
    Varlamov V.P.
    Vikhoreva G.A.
    Pharmaceutical Chemistry Journal, 2004, 38 (2) : 82 - 85
  • [35] EXPRESSION OF LOW-MOLECULAR-WEIGHT CYTOKERATIN PROTEINS IN CERVICAL NEOPLASIA
    BOBROW, LG
    MAKIN, CA
    LAW, S
    BODMER, WF
    JOURNAL OF PATHOLOGY, 1986, 148 (02): : 135 - &
  • [36] LOW-MOLECULAR-WEIGHT CYTOKERATIN PROTEINS IN CERVICAL NEOPLASIA - REPLY
    BOBROW, LG
    MAKIN, CA
    LAW, S
    BODMER, WF
    JOURNAL OF PATHOLOGY, 1986, 150 (01): : 70 - 71
  • [37] LOW-MOLECULAR-WEIGHT PROTEINS IN CHILDREN WITH RENAL-DISEASE
    TOMLINSON, PA
    PEDIATRIC NEPHROLOGY, 1992, 6 (06) : 565 - 571
  • [38] LOW-MOLECULAR-WEIGHT PROTEINS AND THE KIDNEY - PHYSIOLOGICAL AND PATHOLOGICAL CONSIDERATIONS
    HERRERA, GA
    ULTRASTRUCTURAL PATHOLOGY, 1994, 18 (1-2) : 89 - 98
  • [39] OCCURRENCE AND FATE OF LOW-MOLECULAR-WEIGHT HALOCARBON COMPOUNDS IN THE ENVIRONMENT
    ISAACSON, PJ
    TREES, DP
    FISK, JF
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1986, 191 : 1 - ENVR
  • [40] DIFFUSION OF SOME LOW-MOLECULAR-WEIGHT COMPOUNDS IN SODIUM HYALURONATE
    CAMBER, O
    LUNDGREN, P
    ACTA PHARMACEUTICA SUECICA, 1985, 22 (06): : 315 - 320